GLL Health Sciences Fund Ltd Submits SEC Filing
GLL Health Sciences Fund Ltd, identified by CIK number 0001694196, filed a document on March 31, 2026, under Item 3C of the Investment Company Act Section 3(c), according to SEC EDGAR. The filing, with accession number 0001694196-26-000003, specifically addresses Item 3C.7, which pertains to Section 3(c)(7).
Details of the Filing
The document is 10 KB in size and was submitted as part of regulatory requirements for investment companies. Item 3C in the filing refers directly to Section 3(c) of the Investment Company Act, while Item 3C.7 focuses on Section 3(c)(7), according to SEC EDGAR. This filing indicates GLL Health Sciences Fund Ltd’s compliance with these provisions.
Implications of Section 3(c)(7)
As widely-known in investment regulations, Section 3(c)(7) applies to funds whose securities are held by qualified purchasers; in this context, GLL Health Sciences Fund Ltd’s filing aligns with such exemptions. The March 31, 2026, filing, with its specific reference to Item 3C.7, reflects standard procedures for funds seeking this status, according to SEC EDGAR.
